---
name: ADaMViz SubmissionSync
last_updated: 2026-09-06
---

# ADaMViz SubmissionSync Strategy

## Purpose

Clinical scientists answering regulatory and internal clinical questions from
ADaM data must move between general LLM chat and an R environment to execute,
inspect, and refine generated plotting code. This slows iteration and leaves
uncertainty about statistical appropriateness, reproducibility, and review
readiness.

## Positioning

ADaMViz SubmissionSync will win first through submission-oriented trust:
statistically appropriate, inspectable, reproducible, and Pharmaverse-aligned
outputs designed for qualified human review. Persistent study context and rapid
iteration will be introduced progressively without weakening traceability.

## Users

**Primary:** Clinical scientists answering regulatory and internal clinical
questions. They are hiring ADaMViz SubmissionSync to turn questions about ADaM
data into review-ready safety and efficacy visualizations with reproducible R
code, supported by statistical programmers and biostatisticians.

## Boundaries

- Unreviewed outputs may be exported only as drafts.
- Unevaluated plot patterns must be clearly labeled experimental or draft.
- The POC accepts only public, synthetic, or properly de-identified data.
- Confidential patient-level data remains prohibited until the product and its
  outputs are validated, privacy and security controls are qualified, and the
  client approves its use.
- Broader table, listing, and figure support is deferred until after the ggplot
  POC.
- Make no extra assumptions about the business logic or the target environment.
  Do not change requirements or existing interfaces, install new packages, or
  add custom error handling. Ask the user first if any of these changes appear
  necessary.

_Resist a change when:_ It weakens reproducibility, traceability, qualified
human review, the current data-safety boundary, or an approved requirement or
interface.

## Key metrics

- **First-pass quality** — At least 80% of outputs pass statistical-programmer
  and biostatistician review without material correction, measured through a
  versioned evaluation harness and recorded reviewer decisions.
- **Exact reproducibility** — At least 80% of Reviewed outputs reproduce from
  recorded inputs, code, package versions, and execution environment, measured
  through controlled re-execution.
- **Automated turnaround** — Median time from prompt submission to a Verified
  plot and reproducible R code is under one minute, measured through application
  telemetry and automated-check completion timestamps.
- **Human-review turnaround** — Median time from Verified to Reviewed is
  measured separately through the recorded decisions and timestamps of both
  required reviewers. Set its target after the pilot establishes a defensible
  baseline.

## Tracks

### Statistically Appropriate ggplot Generation

Develop reliable generation and conversational refinement of safety and
efficacy visualizations from ADaM and other permitted tabular data.

_Why it serves the approach:_ Statistical appropriateness and first-pass review
quality are the foundation of submission-oriented trust.

### Reproducible, Controlled R Execution

Execute generated R code in a controlled environment while recording inputs,
code, dependencies, environment details, and outputs.

_Why it serves the approach:_ Controlled execution makes results inspectable
and independently reproducible.

### Evaluation, Review, and Traceability

Build the evaluation harness, reviewer workflow, status controls, and audit
evidence needed to distinguish drafts, experimental outputs, and approved
outputs.

_Why it serves the approach:_ Submission-oriented trust depends on measured
quality and qualified human review rather than successful code execution alone.

### Persistent Study Context and Broader TLF Support

After the POC, retain governed study context across conversations and expand
from ggplot visualizations to broader table, listing, and figure workflows.

_Why it serves the approach:_ Context and broader output support increase
clinical value after the trust foundation is established.

## Milestones

- **2026-09-07** — Demonstrate the ADaMViz SubmissionSync proof of concept.
  Client pilot, validation checkpoint, and regulatory-facing review dates will
  be set after client discussion.

## Brand

**One-liner:** Conversational, traceable R visualizations from ADaM data for
validated clinical submission workflows.

**Key message:** ADaMViz SubmissionSync keeps the prompt, permitted input data,
executed R code, visual output, review status, and validation evidence aligned.
SubmissionSync does not imply direct electronic submission to—or validation or
approval by—the FDA.

**R package:** `ADaMViz.SubmissionSync`

**Package title:** From Clinical Questions to Review-Ready Figures and
Reproducible R Code

**Package description:** Generates and conversationally refines `ggplot2`
visualizations from Analysis Data Model (ADaM) datasets and other permitted
tabular data. Executes generated R code in a controlled environment and records
input metadata, code, package versions, outputs, and review status to support
reproducibility, traceability, and validation of clinical reporting workflows.

## References

- [GxP coding-agent guidance](docs/references/gxp-coding-agent-guidance.md) —
  project principles for explicit assumptions, local execution, mocked services,
  governed synthetic data, tests, documentation, and validation evidence.
